OmniComm's TrialMaster EDC Solution Selected by Med Device Manufacturer for Phase IV Cardiovascular Device Study


Fort Lauderdale, FL - November 17, 2009

OmniComm Systems, Inc., one of the fastest growing companies in the EDC marketplace, announced today that a leader in the medical device industry has selected OmniComm’s TrialMaster EDC solution for the data capture of a Phase IV cardiovascular study. The 24-months, 7-site study will enroll 100 subjects.

“We look forward to continuing our successful collaboration with this device company,” remarked Stephen Johnson, COO of OmniComm Systems. “Our flagship EDC solution, TrialMaster, has already proven to be an efficient and reliable data capture system for 12 of this customer’s studies during the past 5 years."

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.